Senti Biosciences, Inc. (SNTI) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for SNTI is $6.00, representing a +546.3% upside from the current price of $0.9283. Price targets range from a low of $6.00 to a high of $6.00.
